Sivanesan Iyyakkannu, Tasneem Shadma, Hasan Nazim, Shin Juhyun, Muthu Manikandan, Gopal Judy, Oh Jae-Wook
Department of Bioresources and Food Science, Konkuk University, Seoul 143-701, Korea.
Department of Chemistry, Faculty of Science, Jazan University, Jazan 45142, Saudi Arabia.
Polymers (Basel). 2022 May 24;14(11):2131. doi: 10.3390/polym14112131.
Chitosan has come a long way in biomedical applications: drug delivery is one of its core areas of imminent application. Chitosan derivatives are the new generation variants of chitosan. These modified chitosans have overcome limitations and progressed in the area of drug delivery. This review briefly surveys the current chitosan derivatives available for biomedical applications. The biomedical applications of chitosan derivatives are revisited and their key inputs for oral drug delivery have been discussed. The limited use of the vast chitosan resources for oral drug delivery applications, speculated to be probably due to the interdisciplinary nature of this research, is pointed out in the discussion. Chitosan-derivative synthesis and practical implementation for oral drug delivery require distinct expertise from chemists and pharmacists. The lack of enthusiasm could be related to the inadequacy in the smooth transfer of the synthesized derivatives to the actual implementers. With thiolated chitosan derivatives predominating the oral delivery of drugs, the need for representation from the vast array of ready-to-use chitosan derivatives is emphasized. There is plenty to explore in this direction.
药物递送是其即将应用的核心领域之一。壳聚糖衍生物是壳聚糖的新一代变体。这些改性壳聚糖克服了局限性,并在药物递送领域取得了进展。本综述简要概述了目前可用于生物医学应用的壳聚糖衍生物。回顾了壳聚糖衍生物的生物医学应用,并讨论了它们在口服药物递送中的关键作用。讨论中指出,大量壳聚糖资源在口服药物递送应用中的使用有限,推测这可能是由于该研究的跨学科性质所致。壳聚糖衍生物的合成以及口服药物递送的实际应用需要化学家和药剂师具备不同的专业知识。缺乏热情可能与合成衍生物向实际实施者的顺利转移不足有关。由于硫醇化壳聚糖衍生物在药物口服递送中占主导地位,因此强调了需要大量现成的壳聚糖衍生物的代表性。在这个方向上有很多值得探索的地方。